Procter & Gamble Hygiene & Health Care Ltd. Falls 4.02%: Bearish Signals and 52-Week Lows Mark the Week

1 hour ago
share
Share Via
Procter & Gamble Hygiene & Health Care Ltd. experienced a challenging week, with its stock price declining 4.02% from Rs.9,379.80 to Rs.9,002.50, underperforming the Sensex which gained 0.57% over the same period. The week was marked by bearish technical signals, a downgrade to a Sell rating, and the stock hitting new 52-week lows on consecutive days, reflecting sustained downward pressure amid subdued financial performance and cautious market sentiment.

Key Events This Week

Jun 8: Stock opens at Rs.9,142.60, down 2.53%

Jun 9: Technical downgrade triggers further decline to Rs.9,028.55 (-1.25%)

Jun 11: Stock hits 52-week low at Rs.8,990

Jun 12: New 52-week low at Rs.8,939.25 despite Sensex gains

Week Open
Rs.9,379.80
Week Close
Rs.9,002.50
-4.02%
Week Low
Rs.8,939.25
vs Sensex
-4.59%

Monday, 8 June 2026: Stock Opens Lower Amid Market Weakness

Procter & Gamble Hygiene & Health Care Ltd. began the week at Rs.9,142.60, down 2.53% from the previous Friday’s close of Rs.9,379.80. This decline was sharper than the Sensex’s 1.33% fall to 34,673.90, signalling early weakness in the stock relative to the broader market. The volume was moderate at 671, indicating cautious trading as investors digested recent developments. The stock’s proximity to its 52-week low hinted at mounting pressure.

Tuesday, 9 June 2026: Technical Downgrade Spurs Further Decline

The stock continued its downward trajectory, closing at Rs.9,028.55, a 1.25% drop on the day. This followed a technical downgrade announced on 25 May 2026, which shifted the rating from Hold to Sell, reflecting deteriorating momentum. The intraday range showed volatility between Rs.9,118.00 and Rs.9,598.40, but selling pressure prevailed. Despite the Sensex rebounding 0.88% to 34,979.26, the stock underperformed significantly, underscoring company-specific challenges.

Fresh entry alert! This Small Cap from Electronics & Appliances sector is already turning heads in our Top 1% club. Get ahead of the market now!

  • - New Top 1% entry
  • - Market attention building
  • - Early positioning opportunity

Get Ahead - View Details →

Wednesday, 10 June 2026: Price Stabilises Amid Market Volatility

The stock price remained largely unchanged at Rs.9,025.75, a marginal decline of 0.03%, as volume dropped to 365. The Sensex fell 0.61% to 34,766.59, reflecting broader market uncertainty. Technical indicators continued to signal bearish momentum, with the stock trading below all key moving averages. The lack of significant price movement suggested a temporary pause in selling pressure, though the overall trend remained negative.

Thursday, 11 June 2026: New 52-Week Low at Rs.8,990 Amid Weak Financials

On 11 June, the stock hit a fresh 52-week low of Rs.8,990, closing at Rs.9,028.85, a slight 0.03% gain on the day but marking a cumulative 4.53% loss over the prior five days. This decline coincided with a broader market downturn, as the Sensex dropped 0.53% to 34,580.95. The stock’s trading range narrowed to Rs.69, indicating subdued volatility despite the bearish trend. The company’s latest quarterly results showed net sales of Rs.941.32 crore, down 5.07%, and EPS at Rs.47.17, the lowest in recent quarters, contributing to investor caution.

Friday, 12 June 2026: Stock Hits New 52-Week Low Despite Sensex Rally

Despite the Sensex rallying 2.20% to 35,342.50, Procter & Gamble Hygiene & Health Care Ltd. declined 0.29% to close at Rs.9,002.50, touching a new 52-week low intraday at Rs.8,939.25. The stock’s underperformance amid a strong market rebound highlighted company-specific pressures. Technical indicators remained bearish, with the stock trading below all major moving averages and momentum oscillators signalling limited recovery potential. The Mojo Score of 38.0 and a Sell rating reinforce the cautious outlook.

Considering Procter & Gamble Hygiene & Health Care Ltd.? Wait! SwitchER has found potentially better options in and beyond. Compare this mid-cap with top-rated alternatives now!

  • - Better options discovered
  • - + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Weekly Price Performance: Stock vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-06-08 Rs.9,142.60 -2.53% 34,673.90 -1.33%
2026-06-09 Rs.9,028.55 -1.25% 34,979.26 +0.88%
2026-06-10 Rs.9,025.75 -0.03% 34,766.59 -0.61%
2026-06-11 Rs.9,028.85 +0.03% 34,580.95 -0.53%
2026-06-12 Rs.9,002.50 -0.29% 35,342.50 +2.20%

Key Takeaways

Bearish Technical Momentum: The downgrade to a Sell rating and the stock’s position below all major moving averages underscore a dominant bearish trend. Monthly MACD and Bollinger Bands confirm downside bias, while weekly indicators show only mild bullish hints insufficient to reverse the trend.

New 52-Week Lows: The stock hit fresh 52-week lows on 11 and 12 June at Rs.8,990 and Rs.8,939.25 respectively, signalling sustained selling pressure and weak investor confidence.

Underperformance vs Sensex: The stock declined 4.02% over the week while the Sensex gained 0.57%, highlighting company-specific challenges amid a mixed market environment.

Financial Concerns: Recent quarterly results showed a 5.07% decline in net sales and EPS at Rs.47.17, the lowest in recent quarters. Despite a strong ROE of 82.27%, valuation metrics such as a high price-to-book ratio of 39 and PEG ratio of 1.8 suggest the stock is priced expensively relative to growth prospects.

Volume and Market Sentiment: On-balance volume indicators show no clear trend, reflecting uncertain buying interest. The Mojo Score of 38.0 and Sell grade reinforce the cautious stance.

Conclusion

Procter & Gamble Hygiene & Health Care Ltd. faced a difficult week marked by a 4.02% decline in its stock price and new 52-week lows despite a resilient Sensex. The technical downgrade to Sell and bearish momentum indicators suggest continued downside risk in the near term. Weak quarterly financials and expensive valuation metrics add to investor caution. While the company maintains strong management efficiency and a net-debt-free balance sheet, these positives have not translated into price support amid broader market and sector pressures. Investors should closely monitor technical developments and fundamental updates before considering exposure to this mid-cap stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News